CPA
AVNS

Clear Point Advisors’s Avanos Medical AVNS Stock Holding History

Clear Point Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$601 – 136
2024
Q3 		$601 Hold
25
– – ﹤0.01% 497
2024
Q2 		$498 Hold
25
– – ﹤0.01% 500
2024
Q1 		$498 Hold
25
– – ﹤0.01% 499
2023
Q4 		$561 Buy
+25
New +$516 ﹤0.01% 480

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Clear Point Advisors's AVNS Position: Q4 2024 in Review

Clear Point Advisors sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 25 shares — an estimated $601 sold.

Clear Point Advisors first reported a position in AVNS in Q4 2023 and held it in 4 quarters. The position peaked at $601 in Q3 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Clear Point Advisors reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Clear Point Advisors sold 25 Avanos Medical shares in Q4 2024, an estimated $601.
  • Clear Point Advisors first reported a position in Avanos Medical in Q4 2023 and held it in 4 quarters.
  • Clear Point Advisors's Avanos Medical position peaked at $601 in Q3 2024.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Clear Point Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.